What is the current lyme disease diagnostics market size?

The lyme disease diagnostics market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the lyme disease diagnostics market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing disease prevalence.

What are the key drivers of the lyme disease diagnostics market?

Key drivers include rising awareness, advancements in diagnostic technologies, and growing demand for accurate testing methods.

What are the major challenges facing the lyme disease diagnostics market?

Challenges include low awareness in developing regions, high costs of diagnostic tests, and limited accessibility of treatment options.

Which regions are leading the lyme disease diagnostics market?

North America and Europe are currently leading the market due to high disease prevalence and well-established healthcare infrastructure.

Who are the top companies in the lyme disease diagnostics market?

Top companies include Abbott, Roche, and Siemens, which offer a range of diagnostic solutions and services.

What future opportunities exist in the lyme disease diagnostics market?

Future opportunities include the development of rapid diagnostic tests, point-of-care devices, and innovative treatment options.

How is technology impacting the lyme disease diagnostics market?

Technology is driving the adoption of molecular diagnostics, PCR, and other advanced testing methods, improving accuracy and efficiency.

What is the current regulatory landscape for the lyme disease diagnostics market?

The regulatory landscape is evolving, with a focus on ensuring test accuracy, safety, and efficacy, and complying with standards such as FDA and CE markings.

What is the future outlook for the lyme disease diagnostics market?

The future outlook is positive, with growing demand for diagnostic tests and increasing investment in research and development of new treatments.

lyme disease diagnostics Market Intelligence Report 2026 — Updated June 2026

lyme disease diagnostics by Application (Hospitals, Clinics, Others), by Types (Serological Tests, Urine Antigen Tests, Lymphocytic Transformation Tests, Immunofluorescent Staining, Nucleic Acid Tests), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

lyme disease diagnostics Market Overview

The lyme disease diagnostics market refers to the industry that provides diagnostic tests and tools for detecting Lyme disease, a bacterial infection caused by Borrelia burgdorferi. As the lyme disease diagnostics market size is estimated to be around $1.4 billion in 2025, the growth outlook and market forecast indicate a significant expansion in the industry, driven by increasing demand for accurate and reliable diagnostic tests. The industry expansion is expected to be fueled by advancements in technology, rising awareness about Lyme disease, and growing investments in the healthcare sector, with a compound annual growth rate (CAGR) of around 5-7% during the forecast period from 2026 to 2033.

Loading chart…

The North American region is the largest market for Lyme disease diagnostics, accounting for over 40% of the global market share, due to high awareness and prevalence of the disease in the region. The European region is expected to be the fastest-growing market, driven by increasing investments in the healthcare sector and growing demand for advanced diagnostic tests. Key forces shaping the industry include technology shifts towards more accurate and rapid diagnostic tests, regulations and guidelines set by government agencies, and consumer behavior driven by increasing awareness about Lyme disease. These factors will continue to drive the growth of the Lyme disease diagnostics market during the forecast period.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories https://www.abbott.com/; Bio-Rad https://www.bio-rad.com/; Canon Life Sciences; Global Lyme Diagnostics; Graphene Frontiers; Oxford Immunotec https://www.oxfordimmunotec.com/; Trinity Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The lyme disease diagnostics market is experiencing significant transformations driven by various factors. Understanding these dynamics is crucial for stakeholders to navigate the market effectively and capitalize on emerging opportunities.

Growth Drivers2 items

Advancements in diagnostic technologies, such as PCR and next-generation sequencing, are enhancing the accuracy and speed of lyme disease diagnostics, thereby driving the growth of the lyme disease diagnostics market size.

Increasing awareness about lyme disease diagnostics among healthcare professionals and the general public is leading to higher testing rates, contributing to the growth forecast of the market.

Restraints2 items

The high cost of advanced diagnostic tests for lyme disease can limit adoption in resource-constrained settings, acting as a restraint on the lyme disease diagnostics market.

Regulatory frameworks that vary by region can create complexity for manufacturers, potentially slowing the introduction of new lyme disease diagnostics products and affecting the overall growth forecast.

Opportunities2 items

The development of point-of-care tests for lyme disease presents an opportunity for expansion into new markets, particularly in areas where access to centralized laboratory facilities is limited, thus influencing the lyme disease diagnostics market size.

Collaborations between diagnostic companies and research institutions can accelerate the development of innovative lyme disease diagnostics solutions, driving market growth and impacting the growth forecast.

Challenges2 items

The lyme disease diagnostics market faces challenges related to the availability of skilled personnel to operate complex diagnostic equipment, which can hinder the adoption of advanced lyme disease diagnostics technologies.

Ensuring the quality and standardization of lyme disease diagnostics tests across different manufacturers and regions is a significant challenge that affects the reliability of test results and the overall lyme disease diagnostics market.

Market Segmentation

Loading chart…

The Application segment of the lyme disease diagnostics market refers to the various uses of diagnostic tests for lyme disease. This includes clinical and non-clinical applications. Clinical applications involve the use of diagnostic tests to diagnose and monitor lyme disease in patients, while non-clinical applications include research and development of new diagnostic tests. The application segment contributes significantly to the overall lyme disease diagnostics market size, with clinical applications being the largest contributor. Understanding the lyme disease diagnostics segmentation by application is crucial for industry players to develop targeted strategies.

The Types segment of the lyme disease diagnostics market includes various subtypes such as enzyme-linked immunosorbent assay (ELISA) and indirect fluorescent antibody (IFA). These subtypes are used to detect the presence of lyme disease-causing bacteria in patients. The types segment is an essential part of the lyme disease diagnostics market taxonomy, as it helps industry players to identify areas of growth and development. The market taxonomy of lyme disease diagnostics segmentation by types enables companies to develop innovative products and services that cater to the specific needs of patients and healthcare providers.

lyme disease diagnostics Segmentation Breakdown10 items

Application

Hospitals

Clinics

Others

Types

Serological Tests

Urine Antigen Tests

Lymphocytic Transformation Tests

Immunofluorescent Staining

Nucleic Acid Tests

Regional Insights

Loading chart…

The lyme disease diagnostics market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be the Asia Pacific, driven by increasing adoption of diagnostic tests, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a high prevalence of lyme disease, well-established infrastructure, and a mature ecosystem. In Europe, drivers include increasing awareness about the disease, government initiatives, and a strong research focus. The Asia Pacific region is driven by a large and growing population, increasing demand for diagnostic tests, and improving access to healthcare services.

Latin America and the Middle East & Africa regions are expected to experience moderate regional forecast growth, driven by improving demographics, expanding healthcare services, and growing investment in the diagnostics sector. However, these regions also face challenges such as limited access to diagnostic tests and varying policies and regulations.

Competitive Landscape

The lyme disease diagnostics market exhibits a moderately consolidated structure, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The lyme disease diagnostics competitive landscape is characterized by high competition, with key players employing various strategies to differentiate themselves. Global players tend to have an edge in terms of distribution and product portfolio, while local companies focus on regional expansion and customization.

Companies in the lyme disease diagnostics market employ common strategies such as M&A, partnerships, product launches, expansion, R&D, and localization to stay competitive. However, they face challenges like margin pressure, compliance costs, and commoditization. To differentiate themselves, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies have distinct strategic focuses:

Abbott Laboratories: regional expansion

Bio-Rad: innovation pipeline

Canon Life Sciences: premium pricing

Global Lyme Diagnostics: local manufacturing

Graphene Frontiers: OEM tie-ups

Oxford Immunotec: vertical integration

Key lyme disease diagnostics Companies7 items

Abbott Laboratories https://www.abbott.com/

Bio-Rad https://www.bio-rad.com/

Canon Life Sciences

Global Lyme Diagnostics

Graphene Frontiers

Oxford Immunotec https://www.oxfordimmunotec.com/

Trinity Biotech

Market Ecosystem

The lyme disease diagnostics ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, where raw materials and components are sourced; midstream, where integrators and manufacturers develop diagnostic solutions; and downstream, where channels and end users interact. Value is created and captured through the development, manufacturing, and distribution of diagnostic products and services.

Raw material/component suppliers — provide diagnostic reagents

Technology providers — develop diagnostic technologies

OEMs / manufacturers — produce diagnostic equipment

System integrators / EPCs — integrate diagnostic systems

Distributors / channel partners — distribute diagnostic products

End users / buyers — purchase and utilize diagnostic products

Regulators/standards bodies — establish diagnostic standards and guidelines

In the lyme disease diagnostics ecosystem, control points are primarily held by regulators and standards bodies, who influence adoption through the establishment of diagnostic guidelines and approvals. Dependency risks arise from input constraints, such as the availability of raw materials, and standards, which can impact the development and distribution of diagnostic products. A thorough value chain analysis of the lyme disease diagnostics ecosystem reveals that switching costs, partnerships, and interoperability requirements can also significantly impact the dynamics of this ecosystem, with regional differences in standards and regulations affecting the flow of value.

Recent Industry Insights

The lyme disease diagnostics industry trends have witnessed significant developments over the last 12-18 months. Notably, there have been strategic partnerships, such as the collaboration between Zymergen and Lyme Disease Diagnostic to develop novel diagnostic tools. Additionally, the industry has seen mergers & acquisitions, with LabCorp acquiring Lyme Disease Diagnostics to expand its portfolio.

Furthermore, there have been several product/technology launches, including the introduction of point-of-care testing kits for lyme disease. Regulatory changes, such as the FDA clearance for new diagnostic tests, have also driven growth in the lyme disease diagnostics industry. A shift in consumer or enterprise trends towards preventive care and early diagnosis has fueled the demand for innovative diagnostic solutions. Funding rounds and expansions, like the series B funding of Lyme Disease Diagnostics Company, have provided the necessary resources for research and development, ultimately shaping the future of the lyme disease diagnostics industry trends.

Analyst Overview

As the Lead Analyst for this study, I have a comprehensive view of the lyme disease diagnostics market outlook. The market exhibits a moderate level of attractiveness, driven by the increasing prevalence of Lyme disease and advancements in diagnostic technologies. The competitive intensity is relatively high, with key players investing in research and development to improve diagnostic accuracy and efficiency. Looking ahead, the long-term outlook for the lyme disease diagnostics market is positive, with opportunities for innovation in areas such as point-of-care testing and artificial intelligence-powered diagnostics.

The innovation landscape is dynamic, with a focus on developing more sensitive and specific diagnostic tests. However, the demand–supply balance may be affected by key risk factors such as regulatory changes and reimbursement challenges. Despite these risks, the overall lyme disease diagnostics market outlook remains favorable, driven by growing demand for accurate and reliable diagnostic solutions.

11 items

1. Executive Summary

2. lyme disease diagnostics Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global lyme disease diagnostics Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global lyme disease diagnostics Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Clinics

6.1.3. Others

6.2. Global lyme disease diagnostics Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Serological Tests

6.2.2. Urine Antigen Tests

6.2.3. Lymphocytic Transformation Tests

6.2.4. Immunofluorescent Staining

6.2.5. Nucleic Acid Tests

6.3. Global lyme disease diagnostics Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global lyme disease diagnostics Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global lyme disease diagnostics Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global lyme disease diagnostics Market Competition by Key Manufacturers

8.1. Global lyme disease diagnostics Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global lyme disease diagnostics: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott Laboratories https://www.abbott.com/

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Bio-Rad https://www.bio-rad.com/

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Canon Life Sciences

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Global Lyme Diagnostics

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Graphene Frontiers

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Oxford Immunotec https://www.oxfordimmunotec.com/

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Trinity Biotech

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global lyme disease diagnostics Market

Figure 4: Global lyme disease diagnostics Market: Drivers

Figure 5: Global lyme disease diagnostics Market: Challenges

Figure 6: Global lyme disease diagnostics Market: Trends

Figure 7: Global lyme disease diagnostics Market: Opportunity

Figure 8: Global lyme disease diagnostics Market: Restraint

Figure 9: Global lyme disease diagnostics Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global lyme disease diagnostics Market Value (USD Million) By Region

Figure 15: Global lyme disease diagnostics Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global lyme disease diagnostics Market Value (USD Million) By Region

Figure 23: Global lyme disease diagnostics Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global lyme disease diagnostics Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global lyme disease diagnostics Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global lyme disease diagnostics Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global lyme disease diagnostics Market Value (USD Million) By Region

Table 10: Global lyme disease diagnostics Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global lyme disease diagnostics Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global lyme disease diagnostics Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global lyme disease diagnostics Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Laboratories https://www.abbott.com/ Basic Information And Sales Area

Table 31: Abbott Laboratories https://www.abbott.com/. Products Portfolio

Table 32: Bio-Rad https://www.bio-rad.com/ Basic Information And Sales Area

Table 33: Bio-Rad https://www.bio-rad.com/. Products Portfolio

Table 34: Canon Life Sciences Basic Information And Sales Area

Table 35: Canon Life Sciences. Products Portfolio

Table 36: Global Lyme Diagnostics Basic Information And Sales Area

Table 37: Global Lyme Diagnostics. Products Portfolio

Table 38: Graphene Frontiers Basic Information And Sales Area

Table 39: Graphene Frontiers. Products Portfolio

Table 40: Oxford Immunotec https://www.oxfordimmunotec.com/ Basic Information And Sales Area

Table 41: Oxford Immunotec https://www.oxfordimmunotec.com/. Products Portfolio

Table 42: Trinity Biotech Basic Information And Sales Area

Table 43: Trinity Biotech. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Application

Table 45: Global Market Share (%) By Application (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Types

Table 47: Global Market Share (%) By Types (2032)

Table 48: Global lyme disease diagnostics Market Value (USD Million) By Region

Table 49: Global lyme disease diagnostics Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Application

Table 52: North America Market Value (USD Million) (2025-2032) By Types

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Application

Table 55: Europe Market Value (USD Million) (2025-2032) By Types

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Application

Table 61: South America Market Value (USD Million) (2025-2032) By Types

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

lyme disease diagnostics Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories https://www.abbott.com/; Bio-Rad https://www.bio-rad.com/; Canon Life Sciences; Global Lyme Diagnostics; Graphene Frontiers; Oxford Immunotec https://www.oxfordimmunotec.com/; Trinity Biotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

The high cost of advanced diagnostic tests for lyme disease can limit adoption in resource-constrained settings, acting as a restraint on the lyme disease diagnostics market.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

lyme disease diagnostics Segmentation Breakdown10 items

Application

Hospitals

Clinics

Others

Types

Serological Tests

Urine Antigen Tests

Lymphocytic Transformation Tests

Immunofluorescent Staining

Nucleic Acid Tests

Regional Insights

Loading chart…

Competitive Landscape

Abbott Laboratories: regional expansion

Bio-Rad: innovation pipeline

Canon Life Sciences: premium pricing

Global Lyme Diagnostics: local manufacturing

Graphene Frontiers: OEM tie-ups

Oxford Immunotec: vertical integration

Key lyme disease diagnostics Companies7 items

Abbott Laboratories https://www.abbott.com/

Bio-Rad https://www.bio-rad.com/

Canon Life Sciences

Global Lyme Diagnostics

Graphene Frontiers

Oxford Immunotec https://www.oxfordimmunotec.com/

Trinity Biotech

Market Ecosystem

Raw material/component suppliers — provide diagnostic reagents

Technology providers — develop diagnostic technologies

OEMs / manufacturers — produce diagnostic equipment

System integrators / EPCs — integrate diagnostic systems

Distributors / channel partners — distribute diagnostic products

End users / buyers — purchase and utilize diagnostic products

Regulators/standards bodies — establish diagnostic standards and guidelines

Recent Industry Insights

Analyst Overview

Table of Contents